EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Planning adaptive trials supporting conditional and permanent registration using the same primary endpoint

Liane Kluge iD, Werner Brannath iD

Statistical Methods in Medical Research · 20.11.2026

DOI: 10.1177/09622802261508998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistical Methods in Medical Research, online erschienen am 20.11.2026. Verfasst von Liane Kluge und 1 weiteren Autor:innen. Beteiligte Einrichtung: Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Freie Hansestadt Bremen, Leibniz Institute for Prevention Research and Epidemiology - BIPS, Leibniz Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fast-track procedures involve an intermediate registration step that enables earlier patient access to innovative medical products. Applicants can first apply for conditional registration with only limited evidence for therapeutic effects, leading to a limited funding or approval period and time to prepare the application for permanent registration with more convincing evidence. This article investigates the underexplored option of achieving conditional registration with a kind of weak evidence in the same primary endpoint used later for permanent registration. This is possible with the EMA’s conditional marketing authorization and is the preferred two-stage strategy in the German DiGA fast-track program for the reimbursement of digital therapeutics. We carefully discuss regulatory requirements, valid and efficient study designs as well as power considerations for such fast-track registration strategies. In particular, we propose two-stage adaptive designs that use the first-stage data for conditional registration and for planning the permanent registration study, where the decision on permanent registration can then be based on the data from both stages. The designs include an interim sample size recalculation for achieving a target conditional power and aim to achieve a target overall probability for conditional and permanent registration. This requires specific minimum and maximum sample sizes. By analyzing these sample sizes as well as expected ones, we show that adaptive designs usually perform much better than designs with separate studies for conditional and permanent registration.

Schlagwörter

Stichwörter der Autor:innen

Confirmatory adaptive designconditional approvaldigital therapeutics (DTx)efficient study designsample size recalculation

Autor:innen und Institutionen

  • Competence Center for Clinical Trials Bremen, University of Bremen, Bremen, Germany.
  • Institute for Statistics, University of Bremen, Bremen, Germany.

ORCID-Profile: Liane Kluge, Werner Brannath

Förderung

  • Freie Hansestadt Bremen
  • Leibniz Institute for Prevention Research and Epidemiology - BIPS
  • Leibniz Association

Zitieren

APA

Kluge, L., & Brannath, W. (2026). Planning adaptive trials supporting conditional and permanent registration using the same primary endpoint. Statistical Methods in Medical Research. https://doi.org/10.1177/09622802261508998

Vancouver

Kluge L, Brannath W. Planning adaptive trials supporting conditional and permanent registration using the same primary endpoint. Statistical Methods in Medical Research. 2026. doi:10.1177/09622802261508998

BibTeX
@article{Kluge2026,
  author = {Kluge, Liane and Brannath, Werner},
  title = {Planning adaptive trials supporting conditional and permanent registration using the same primary endpoint},
  journal = {Statistical Methods in Medical Research},
  year = {2026},
  doi = {10.1177/09622802261508998}
}
Kostenlos starten →